(1)
Efficacy Levels of Recombinant Tetravalent Dengue Vaccine (Cyd-Tdv) in Children Aged 2-16 Years: Meta-Analysis. JISIP 2024, 8 (3), 1583-1591. https://doi.org/10.58258/jisip.v8i3.6988.